IPILIMUMAB

作品数：44被引量：96H指数：7
导出分析报告
相关领域：医药卫生更多>>
相关作者：谢宗宙林飞燕胡章国周严韩宝惠更多>>
相关机构：海口市人民医院上海市胸科医院东南大学中国科学院更多>>
相关期刊：《细胞与分子免疫学杂志》《华西医学》《Journal of Pharmaceutical Analysis》《临床皮肤科杂志》更多>>
相关基金：国家自然科学基金北京市自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 主题=IMMUNEx
共 条 记 录，以下是1-6
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Long-Term Persistent Absolute Insulin Secretion Deficiency in Diabetes Induced by Immune Checkpoint Inhibitors
《Open Journal of Endocrine and Metabolic Diseases》2023年第12期227-233,共7页Moctar Bah Clara Bouché Jean-François Gautier 
Immune checkpoint inhibitors are today an immense hope in the management of cancers. However, since their widespread use, many cases of insulin-requiring diabetes appearing suddenly, as fulminant diabetes have been re...
关键词：Immune Checkpoint Inhibitors Nivolumab IPILIMUMAB Fulminant Diabetes Insulin-Requiring Diabetes 
The tumor microenvironment of pancreatic adenocarcinoma and immune checkpoint inhibitor resistance: a perplex relationship
《Cancer Drug Resistance》2020年第4期699-709,共11页Irem Sahin Sevda Turen Pranav Santapuram Ibrahim Halil Sahin 
Pancreatic cancer is one of the most aggressive cancers with a high mortality rate even among patients with early-stage disease.Although recent studies with novel therapeutic approaches have led to modest improvement ...
关键词：Pancreatic adenocarcinoma durvalumab nivolumab IPILIMUMAB pembrolizumab immune checkpoint inhibitors immunotherapy resistance mismatch repair deficient microsatellite instability high microsatellite stable tumor-associated macrophages myeloid-derived suppressor cells T regs T cells 
Immune Checkpoint Inhibitor Related Neuropathic Adverse Effects on Cancer Patients
《Journal of Biosciences and Medicines》2019年第6期1-12,共12页Samrat Khanal Haijun Zhang 
With the recent development and clinical application, immune checkpoint inhibitors (ICIs) intervention is being increasingly common for multiple malignancies. With these, prospect on focus creates an increasing necess...
关键词：Immune-Related ADVERSE Events IMMUNE CHECKPOINT Inhibitors Nivolumab IPILIMUMAB Lung Cancer Melanoma 
Managing cardiotoxicity associated with immune checkpoint inhibitors被引量：11
《Chronic Diseases and Translational Medicine》2019年第1期6-14,共9页Sireesha Upadhrasta Hadi Elias Keval Patel Lei Zheng 
Immuno-oncology is a fast evolving field of cancer therapy and immune checkpoint inhibitors (ICIs) are clearly a breakthrough in this field. Cardiotoxicity with conventional anti-cancer therapies has been well studied...
关键词：IMMUNE CHECKPOINT INHIBITOR CARDIOTOXICITY IPILIMUMAB Nivolumab Pembrolizumab 
Ipilimumab associated colitis: An Ipi Colitis case series at Med Star Georgetown University Hospital
《World Journal of Gastroenterology》2015年第14期4373-4378,共6页Pawan Rastogi Mohamed Sultan Aline J Charabaty Michael B Atkins Mark C Mattar 
Supported by Med Star Georgetown University Hospital,Washington,DC,United States
Although ipilimumab has been shown to improve survival in patients with metastatic melanoma and cause regression of metastatic renal cell carcinoma, the associated immune-related toxicities are of concern.The resultan...
关键词：COLITIS IPILIMUMAB IMMUNOLOGY INFLIXIMAB Immune-re 
Present and future of immune checkpoint blockade: Monotherapy to adjuvant approaches
《World Journal of Immunology》2015年第1期1-15,共15页Mira A Patel Jennifer E Kim Jacob Ruzevick Michael Lim 
Immune regulation of aggressive tumor growth is often outpaced by tumor up-regulation of ligands that inhibit effector immune responses through the activation of immune checkpoints. A few of such checkpoints include p...
关键词：Programmed death-1 CYTOTOXIC T LYMPHOCYTE associated antigen-4 IPILIMUMAB Nivolumab IMMUNE checkpoint 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部